The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Selective ASO-based JAK2 inhibitor for the treatment of hematological malignancies with JAK2 V617F mutation burden.
 
Sandra Smieszek
Employment - Vanda Pharmaceuticals
Stock and Other Ownership Interests - Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Vanda Pharmaceuticals
 
Bartlomiej Przychodzen
Employment - Vanda Pharmaceuticals
Stock and Other Ownership Interests - Vanda Pharmaceuticals